Healthcare / Medical Care FacilitiesSaudi
$26.88
+0.10 (+0.37%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $250.4M · quality 72.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
48/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$4.3B
P/E
19.2x
↓EV/EBITDA
12.0x
↓ROE
12.1%
↑Gross Margin
29.4%
↓Debt/Equity
0.14
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+3.2%
FCF CAGR
-6.3%
FCF margin
9.4%
FCF / Net income
0.48x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.23B · net income $241.9M · FCF $115.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.23B | $1.23B | $1.15B | $1.18B | $1.12B |
| Net Income | $241.9M | $241.9M | $338.8M | $303.3M | $257.3M |
| EBITDA | $371.6M | $371.6M | $475.5M | $446.9M | $396.3M |
| EPS | — | — | 2.12 | 1.90 | 1.61 |
| Gross Margin | 29.4% | 29.4% | 33.1% | 36.8% | 37.4% |
| Operating Margin | 19.2% | 19.2% | 25.1% | 27.6% | 25.0% |
| Net Margin | 19.6% | 19.6% | 29.4% | 25.8% | 22.9% |
| Balance Sheet | |||||
| Debt/Equity | 0.14 | 0.14 | 0.16 | 0.17 | 0.21 |
| Cash Flow | |||||
| Free Cash Flow | $115.9M | $115.9M | $250.4M | $296.2M | $140.7M |
| Returns | |||||
| ROE | 12.1% | 12.1% | 17.3% | 16.4% | 15.0% |
| Valuation | |||||
| P/E | 19.20 | 19.20 | 18.16 | 31.89 | 27.95 |
| EV/EBITDA | 12.00 | 12.00 | 13.08 | 22.12 | 18.93 |
| P/B | 2.14 | 2.14 | 3.14 | 5.26 | 4.21 |
| Growth & Yield | |||||
| Revenue Growth | 7.0% | 7.0% | -1.9% | 4.8% | — |
| EPS Growth | — | — | 11.6% | 18.0% | — |
| Dividend Yield | 3.0% | 3.0% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-24.1%
Start / end P/E
n/dx → n/dx
EPS bridge
2.12 → n/d
Residual
-27.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.